Skip to content
Home/Companies/HealthTech/Bodyport
Bodyport

Bodyport

HealthTech·United States·Active·6yr hold
Entry
2020
Hold
6yr
Status
Active

Who owns Bodyport?

Bodyport is an American HealthTech company, currently owned by Boehringer Ingelheim Venture Fund since 2020.

Hand-verified · updated 2026-07-07

Open JSON · CC-BY
Boehringer Ingelheim Venture Fund
Investor
Boehringer Ingelheim Venture Fund
Boehringer Ingelheim Venture Fund · 2010 · Evergreen

Key facts

HQUnited States
SectorHealthTech
StatusActive
Websitewww.bodyport.com

More from Boehringer Ingelheim Venture Fund

Other portfolio companies in the same fund.

ICD Therapeutics
Exited 2019
BiotechGermany
to Boehringer Ingelheim
EvlaBio
Active
BiotechGermany· 2025
ProTgen
Active
BiotechUS· 2024
Refoxy Pharmaceuticals
Refoxy Pharmaceuticals
Active
BiotechGermany· 2024
SwitchKine
Active
BiotechSwitzerland· 2024
Synthetica Pioneering
Active
BiotechChina· 2024

More PE-backed in HealthTech

Comparable healthtech deals from other GPs.

52North Health
52North Health
Active
Future Planet CapitalUK
A Place for Mom
A Place for Mom
Active
Silver LakeUS
Advance Medical
Active
Summit PartnersUS
AdvancedMD
AdvancedMD
Active
Francisco PartnersUS
Agilio Software
Agilio Software
Active
TA AssociatesUS
agilon health
agilon health
Active
CD&RUS

Questions

Who owns Bodyport?

Bodyport is currently owned by Boehringer Ingelheim Venture Fund, through Boehringer Ingelheim Venture Fund, since 2020.

When did Boehringer Ingelheim Venture Fund acquire Bodyport?

Boehringer Ingelheim Venture Fund acquired Bodyport in 2020.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue